differential epigenetic profiles) for epigenetic involvement in the most prevalent and severe psychiatric illnesses. We will end the article by discussing current research challenges in epigenetic epidemiology and neuroscience, and we propose that more studies combining epidemiological and neuroscience approaches in studying epigenetics are needed to improve our understanding of the role of the epigenetic machinery in the etiologies of psychiatric disorders. Besides robust changes in reprogramming of genomic methylation patterns in germline cells as well as in pre-implantation embryos [78] . In autism, a 10-year increase in paternal age (independent of maternal age) was associated with a 22% increased risk for autism (independent of paternal age) while a 10-year increase in maternal age has been associated with a 38% increased risk for developing the disorder [78, 79] , which is in line with other findings reporting associations between parental ages and autism [80] [81] [82] . A recent metaanalysis on the association between paternal age and schizophrenia reported that both advanced paternal age (>/=30) and younger paternal age (<25) may increase the risk of schizophrenia, with further analyses indicating that younger paternal age may be associated with particularly an increased risk in male but not female offspring [83] . Given these effects of paternal (and maternal age) on risk of several psychiatric disorders, one could speculate that 
Introduction
differential epigenetic profiles) for epigenetic involvement in the most prevalent and severe psychiatric illnesses. We will end the article by discussing current research challenges in epigenetic epidemiology and neuroscience, and we propose that more studies combining epidemiological and neuroscience approaches in studying epigenetics are needed to improve our understanding of the role of the epigenetic machinery in the etiologies of psychiatric disorders. histone modifications, occurring at specific residues, have been described (eg, acetylation, methylation, phosphorylation, SUMOylation, and ubiquitylation), which together constitute a complex "histone code" modulating gene expression via alterations in chromatin structure [4] . Histone acetylation is linked with transcriptional activation, while deacetylation is related to transcriptional repression [4] .
Epigenetic mechanisms

Non-coding RNAs and Genetic imprinting
MicroRNAs (miRNAs) are small regulatory RNAs that individually regulate up to several hundred genes, and collectively may regulate as much as two-thirds of the transcriptome [5] . Another relevant epigenetic mechanism is genomic imprinting, the phenomenon by which certain genes are expressed in a parent-of-originspecific manner, independently of classical Mendelian inheritance. Imprinted genes are expressed only from the allele inherited from one of the two parents.
Epigenetics and development of the brain
Pioneering work in the last decade has uncovered epigenetic regulation of gene transcription as fundamental for normal development and functioning of the organism, especially in relation to appropriate responses to stimuli [6] . to be grossly normal at birth [7, 8] , mice lacking Dnmt3a do acquire developmental defects in postnatal life and die prematurely [7] .
Besides robust changes in reprogramming of genomic methylation patterns in germline cells as well as in pre-implantation embryos [9] , it has become clear that dynamic changes occur in the patterns of DNA methylation, histone alterations and expression of microRNA's throughout life and especially during development. Brain development involves cellular processes such as cellular proliferation, cellular differentiation, and maturation [10] , but also myelination [11] , and synaptic plasticity, and accumulating evidence indicates that these processes depend on appropriate epigenetic regulation [12] . Recent experimental animal studies have, for example, established that the functional abilities of memory formation, learning, motivation and reward are all linked to epigenetic regulation of gene expression [13] [14] [15] . Genetic manipulation of Dnmt1 and Dnmt3a in mice has shown that long-term plasticity (which underlies learning and memory) in the mouse hippocampus depends critically on these major DNA methyltransferase enzymes [16] . Experiencedriven developmental changes are furthermore known to impact at different biological levels, such as membrane depolarization, calcium influx, and induction of transcription factors [17] , and recent studies have discovered that sustainable effects of developmental exposures and experiences are mediated (and reflected) by epigenetic alterations [18] , as discussed in more detail below. Evidence that humans with mutations in gene encoding methyl CpGbinding protein 2 (Mecp2) frequently show markedly decreased cognitive performances is furthermore in line with this notion.
Epigenetics and aging
Epigenetic changes are proposed to have crucial impact on early life programming and thereby on neurodevelopmental disorders [19] , but also affect age-related changes in the brain. Recent work reports that epigenetic markings are subject to change with advancing age [20, 21] While earlier work suggested that aging was associated with a global loss of DNA methylation, more recent work indicates that age-related changes are also CpG-island dependent [20] [21] [22] . By investigating human tissues at 1,413 autosomal CpG loci associated with 773 genes, Christensen et al. observed highly significant CpG island-dependent correlations between age and methylation; loci in CpG islands gained methylation with age, loci not in CpG islands lost methylation with age [22] . Another large scale study using human brain tissue identified CpG loci, primarily CpG islands, with consistent positive correlation between DNA methylation, and chronological age [23] . In addition, recent findings on an aging mouse cohort kept under controlled environmental conditions throughout live showed that the level of the major de novo methylation enzyme Dnmt3a increased with age in the hippocampus [24] , and correlated with age-related increase in levels of 5-methyl cytidine (5-mC). The same study showed that caloric restriction, which increases lifespan and prevents age-related alterations and pathology in various animal species [25] [26] [27] [28] , was able to prevent these age-related changes in hippocampal levels of Dnmt3a [24] and 5-mC (Prevention of age-related changes in hippocampal levels of 5-methylcytidine by caloric restriction [29] . The speculation of a causal involvement of epigenetic mechanisms in age-related decline of functional abilities of the brain [30] is in line with i) findings that age-related memory disturbances in mice are associated with altered chromatin plasticity (in particular with dysregulation of H4k12ac) in the hippocampus [31] , and ii) the link between sirtuins, i.e. molecules which deacetylase H4K16ac in a Nicotinamide adenine dinucleotide -dependent manner, and life span [32] . Thus, epigenetic mechanisms appear to be fundamentally involved in the neurobiological processes that govern development [19] and aging of the brain [21] , and gives credibility to the speculation that epigenetic mechanisms are involved in the formation of an individuals' functional abilities and personality characteristics, as well as in neurodevelopmental and neurodegenerative trajectories of psychopathology [1, 32, 33] .
Genetic imprinting and psychiatry
The crucial role of genetic imprinting in However, very detailed analyses on MZ twin pairs discordant for multiple sclerosis [47] indicated that the puzzle of explaining MZ twin discordance is far from being solved.
Epigenetics and twin discordance in psychiatric disorders
Analyses of the genome sequences of a MZ twin pair discordant for multiple sclerosis, and messenger RNA transcriptome and epigenome sequences of lymphocytes from 3 MZ twin pairs discordant for multiple sclerosis failed to detect reproducible differences in approximately 3.6 million single nucleotide polymorphisms and approximately 0.2 million insertion-deletion polymorphisms between the co-twins [47] .
Although the detailed analyses did detect 2 to 176 differences in the methylation of approximately 2 million CpG dinucleotides between siblings of the 3 twin pairs, it is unlikely that these methylation differences can fully explain disease discordance [47] . 
Epigenetics and sex differences in psychiatric disorders
The onset, course and phenomenology of psychiatric disorders often show sexual differentiation [51, 52] . Female sex has consistently been associated with increased risk of depressive disorders [53] and anxiety disorders such as panic disorder, posttraumatic stress disorder and social phobia [54] , while male sex is associated with ADHD
[55], autism spectrum disorders [55] [56] [57] , and substance abuse disorders [58] . Sexual differentiation is furthermore apparent in age of onset, phenomenology and developmental trajectories towards psychopathology [59, 60] . reported to increase during development [62] .
Another epigenetic mechanism giving rise to sexual differentiation is X-chromosome inactivation. X-inactivation is the irreversible epigenetic process that involves silencing of one of the two X-chromosomes in female individuals during early development [63] .
X-inactivation is estimated to take place just before the morula stage when the human embryo contains less than 16 cells [64, 65] .
Previous studies have shown that the timing of X-inactivation is associated with the timing of chorionic twinning [64] : dichorionic monozygotic (DC-MZ) twinning is estimated to take place at, or before the morula stage (so, just at or before X-inactivation) and the monochorionic monozygotic (MC-MZ)
twinning event occurs after the morula stage (and consequently after X-inactivation) [64] .
Consistent with the notion that individuals
who are members of DC-MZ twins are separately subject to X-inactivation, patterns of X-inactivation are more identical in MC-MZ twins than in DC-MZ twins [64, 66] . Thus, found evidence that was suggestive for a role of X-inactivation in bipolar disorder.
The index of X-inactivation showed a borderline statistically significant difference for discordant bipolar disorder twin pairs as compared to controls [69] . Nevertheless, the role of X-inactivation in behavioral traits and psychiatric disorders has only received very little research interest thus far and urgently requires further exploration.
transgenerational epigenetics inheritance in psychiatric disorders
Epigenetic marks can be transmitted across generations [70] [78] . In autism, a 10-year increase in paternal age (independent of maternal age) was associated with a 22% increased risk for autism (independent of paternal age) while a 10-year increase in maternal age has been associated with a 38% increased risk for developing the disorder [78, 79] , which is in line with other findings reporting associations between parental ages and autism [80] [81] [82] . A recent metaanalysis on the association between paternal age and schizophrenia reported that both advanced paternal age (>/=30) and younger paternal age (<25) may increase the risk of schizophrenia, with further analyses indicating that younger paternal age may be associated with particularly an increased risk in male but not female offspring [83] . Given these effects of paternal (and maternal age) on risk of several psychiatric disorders, one could speculate that paternal and maternal age influence general functional abilities of the offspring's brain rather than inducing abnormalities specific for a certain disorder. An interesting recent study on 33,437 children drawn from the US Collaborative Perinatal Project reported that offspring of older fathers were impaired in tests of neurocognitive ability (at an age of 7 years) while advanced maternal age was associated with better neurocognitive abilities [84] . The pattern of childhood behavioral problems in the same population was also differentially affected by advanced paternal age as compared with advanced maternal age: while advanced paternal age was associated with externalizing behaviors in the offspring but not with internalizing behavioral outcomes, advanced maternal age was significantly protective against externalizing behavioral outcomes, but associated with an increased risk of internalizing behavioral problems [85] . Evidence that, at least for some disorders, both high and low paternal or maternal age were associated with increased risk of psychopathology, e.g. in autism [80] and schizophrenia [83] , is in line with the concept of the existence of an optimal (epigenetic- 
Environmental epigenetic in psychiatric disorders
A wealth of epidemiologic evidence indicates that environmental exposures influence susceptibility to disease in later life [19, 49] . [103] . A recent study provided evidence that individuals from the Dutch Hunger winter who were exposed to famine prenatally showed hypomethylation at the imprinted IGF2 gene when compared to their unexposed same-sex siblings 6 decades after the period of severe famine [116] ; an association that was specific for peri-conceptional exposure to famine, thus suggesting crucial relevance of epigenetic mechanisms in very early mammalian development [116] . Several nutritional factors such as deficiencies of vitamin A or D, protein content, essential fatty acids, and folate have furthermore been proposed to mediate the increased risk of psychiatric disorders in offspring subjected to famine during fetal development [117] . A large birth cohort study with data on schizophrenia in adulthood indicated that elevated homocysteine levels in the third trimester of pregnancy were associated with an increased risk of schizophrenia in the offspring [96] . A study in which birth interval was used as a proxy of 
Drugs of abuse
Evidence from epidemiological studies and meta-analyses has established that cannabis and other drugs of abuse can be considered risk factors for later psychotic symptoms or psychotic disorders [132] [133] [134] . The age (or developmental stage) at which individuals start using cannabis influences this association [135] . Further evidence suggests that geneenvironment interactions are likely implicated in the association between cannabis and psychosis [133, [136] [137] [138] [139] . For example, the psychotomimetic effect of cannabis is much greater in siblings of patients with a psychotic disorder, who are at increased genetic risk to develop psychotic disorder than in controls [140] . Cannabis use increased the risk for developing psychotic symptoms and schizophreniform disorder only in carriers with the valine158 allele in the Comt gene [136] , while the risk-increasing effects of cannabis on psychosis expression were moderated by genetic variation in Akt1 in another study [138] . The primary psychoactive component of cannabis is Δ9-tetrahydrocannabinol (THC), which is thought to exert its effects through cannabis-1 receptor-mediated signaling [141] .
Administration of THC or cannabis elicits long term molecular and cellular changes in the brains of mice and humans [142] [143] [144] [145] as well as on electrophysiological and biochemical measures of neuronal signaling in brain structures such as nucleus accumbens and hippocampus [146] with differential effects by duration of exposure and timing during development [146] [147] [148] [149] . The abuse of psychostimulants, such as cocaine and amphetamine, has also consistently been associated with major psychotic disorders and substance use disorders. Many drugs of abuse may act via the common mechanism of sensitization addiction and psychosis. In humans and animals, repeated exposure to psychostimulants induces a sensitized state [150] . Sensitized animals share a number of neurobiological changes such as long term alterations of mesolimbic and prefrontal dopaminergic neurotransmission while also expressing behavioral abnormalities [150] . In addition, acute exposure to drugs of abuse provokes transient increases in cFos and other members of the Fos family of transcription factors in the striatum [151] . The majority of these Fos factors become desensitized during chronic abuse, with the exception of ΔFOSB, which itself stimulates the expression of other genes, such as Cdk5 [152, 153] ΔFOSB accumulates in the nucleus accumbens and dorsal striatum and remains detectable for several weeks after cessation of drug administration, suggesting a role in the onset of addiction [153] . In mouse models of cocaine response, the upregulation of cFos and ΔFOSB upon acute administration is accompanied by transient H4 hyperacetylation at the cFos and FosB gene promoters [154] . Chronic exposure, however, does not result in H4 hyperacetylation but is associated with H3 hyperacetylation of the FosB promoter, without an effect on the cFos promoter.
H3 hyperacetylation of cdk5 and Bdnf associated with chronic, but not acute, drug use was also detected after chronic cocaine administration, and persisted even one week after administration ceased [154] . These findings implicate epigenetic mechanisms in the development of addiction, and particularly in the immediate and sustained behavioral effects of cocaine use [154] . Human studies also showed enduring changes in gene expression in subjects exposed to psychostimulants. For example, prolonged exposure to amphetamine is associated with long-term reductions of dopamine transporter density in the brain as measured by in vivo imaging studies [155] . Exposure to cannabis, cocaine and phencyclidine have long lasting effects on intracerebral gene expression, and recent evidence suggests that in fact these drugs may all affect common neurobiological pathways. In a recent post-mortem study using human brain tissue samples, exposures to cannabis, cocaine and phencyclidine were associated with many transcriptional changes in the brain [156] . Hierarchical clustering of these transcripts indicated that genes from the calmodulin signaling cluster were predominantly affected in the brains of abusers, which may be of particular importance given that enhanced dopamine release due to sensitization depends on calmodulin signaling [157, 158] . neurotransmitters [176] . Dysfunction of the one-carbon metabolism has been linked to a range of disorders including neural tube defects [177, 178] , autism [179] , leukemia [180, 181] , dementia [182] [183] [184] , colorectal cancer [183, 185] , cardiovascular disease [186] and congenital abnormalities [187, 188] . Genetic studies on associations between genetic variants in Mthfr and various major psychiatric disorders such as schizophrenia, bipolar disorder and unipolar depressive disorder, have yielded largely inconclusive and often mixed results [189] [190] [191] [192] [193] [194] [195] . Given the essential role of Mthfr in brain function and neurodevelopment [196, 197] , and the fact that family and twin studies have established considerable shared genetic variance between psychiatric disorders [198] [199] [200] , a recent meta-analysis (on a total of more than 29,000 subjects) tested whether genetic variation in Mthfr contributes to the shared genetic vulnerability of schizophrenia, bipolar disorder and unipolar depressive disorder [201] . This meta-analysis showed 
Histone modification genes
A recent large meta-analysis suggested that common variants located at chromosome 6p22.1 in a cluster of the histone genes Hist1h2bj, Hist1h2ag, Histh2bk, Hist1h4i and Hist1h2ah, are associated with an increased risk of schizophrenia [206] . Although the observed associations may be linked haplotypes that include susceptibility alleles in many genes, the strongest association was observed for a region in and near a cluster of histone protein genes, making variants in histone coding genes prime candidates for further analysis, at least in schizophrenia.
Epigenetic epidemiology in psychiatric disorders
Depression, PTSD and suicide control subjects (n=10) in the orbital frontal cortex but not in cerebellum [61] .
Schizophrenia and bipolar disorder
Early studies primarily focused on differential epigenetic marks in specific candidate genes in post-mortem brain tissue. Such studies reported DNA methylation differences associated with schizophrenia in Comt [209] and reelin (Reln) using methylation-specific PCR [210] , although studies using full quantitative methylation profiling methods did not confirm these findings [211] [212] [213] . Post-mortem analyses of cortical GABA-ergic neurons in schizophrenia have shown increased levels of Dnmt1 that was associated with altered expression of reelin or Gad67 [210, 214] . As discussed earlier, 
Alzheimer's disease
Decreased global levels of DNA methylation were observed in the entorhinal cortex of Alzheimer's disease patients using immunohistochemical analyses [216] . between control and Alzheimer's disease patients [217] . DNA methylation was decreased in the promoter region of the tau protein gene in the parietal cortex but its transcription was downregulated [218] . In a postmortem analysis of the frontal cortex and hippocampus, no (Fig. 1A) , the approximate timing of risk-increasing exposures (Fig. 1B) , epigenetic marks that can be inherited or acquired over life, as a possible consequences of exposures (Fig 1C.) , timing of neurodevelopmental processes (Fig. 1D) , and the temporal sequence of the expression of psychiatric phenotypes (Fig. 1E) . Exposures depicted in 1B may thus induce epigenetic alterations on the molecular level that may impact on crucial neurobiological processes during sensitive periods of neurodevelopment, and may synergistically give rise to aberrations in mental health, phenotypically expressed by quantitative (and/ or qualitative) alterations in psychological functions that in interaction with the individual's social world may result into psychiatric disorder. Black circles in 1C represent epigenetic modifications to DNA (e.g. methylated cytosines or histone modifications). The row represents a nucleus of a post-mitotic cells with dynamic changes to DNA modifications which may accumulate within the individual throughout development as a consequence of the synergistically combination of multiple exposures. These dynamic changes in DNA methylation may be associated with aberrations in neurodevelopmental processes such as for example myelination (Fig 1D) , and the appearance of subclinical psychotic symptoms (Fig.1E ) that can become abnormally persistent and ultimately lead to the onset of a major psychotic disorder (Fig 1E) . Whilst this figure illustrates that development of major psychotic disorders is associated with accumulation of DNA modifications of a gene, other scenarios where removal of epigenetic modifications at a specific gene is associated with disorder, are equally possible.
